(Q34440858)

English

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

object named as

Walter Jonat

0 references

5

object named as

Richard Greil

1 reference

Europe PubMed Central

2 August 2017

author name string

Raimund Jakesz

1

1 reference

Europe PubMed Central

2 August 2017

Michael Gnant

3

1 reference

Europe PubMed Central

2 August 2017

Martina Mittlboeck

4

1 reference

Europe PubMed Central

2 August 2017

Christoph Tausch

6

1 reference

Europe PubMed Central

2 August 2017

Joern Hilfrich

7

1 reference

Europe PubMed Central

2 August 2017

Werner Kwasny

8

1 reference

Europe PubMed Central

2 August 2017

Christian Menzel

9

1 reference

Europe PubMed Central

2 August 2017

Hellmut Samonigg

10

1 reference

Europe PubMed Central

2 August 2017

Michael Seifert

11

1 reference

Europe PubMed Central

2 August 2017

Guenther Gademann

12

1 reference

Europe PubMed Central

2 August 2017

Manfred Kaufmann

13

1 reference

Europe PubMed Central

2 August 2017

Johann Wolfgang

14

1 reference

Europe PubMed Central

2 August 2017

ABCSG and the GABG

15

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 August 2005

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

366

1 reference

Europe PubMed Central

2 August 2017

455-462

1 reference

Europe PubMed Central

2 August 2017

9484

1 reference

Europe PubMed Central

2 August 2017

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Five years of tamoxifen--or more?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of tamoxifen for breast cancer: twenty-eight years later

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Annual hazard rates of recurrence for breast cancer after primary therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Omission of histologic grading from clinical decision making may result in overuse of adjuvant therapies in breast cancer: results from a nationwide study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-aromatase agents in the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967059-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)67059-6

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34440858&oldid=1962104441"